1. Stocks
  2. Krystal Biotech Inc
  3. Swot
swot-logo

Krystal Biotech Inc SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Krystal Biotech Inc has 10 Strengths, 15 Weaknesses, 0 Opportunities and 4 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Annual Profit Growth higher than Sector Profit Growth

Good quarterly growth in the recent results

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Efficient in managing Assets to generate Profits - ROA improving since last 2 year

Companies with Low Debt

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Top Gainers

Volume Shockers

Promoter decreasing their shareholding

Companies with growing costs YoY for long term projects

PE higher than Industry PE

PEG greater than Industry PEG

Expensive Underperformers (DVM)

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Near 52 Week Low

Declining Net Cash Flow : Companies not able to generate net cash

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

Mutual Funds Decreased Shareholding in Past Month

Red Flags: Weakening Technicals and Share Price Decline

MFs decreased their shareholding last quarter

Institutions decreased their shareholding last quarter

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks